The preferred treatment for stage I seminoma: a survey of Canadian radiation oncologists

Clin Oncol (R Coll Radiol). 2006 Nov;18(9):696-9; discussion 693-5. doi: 10.1016/j.clon.2006.06.008.

Abstract

Aims: To evaluate the preferences of radiation oncologists for managing stage I seminoma.

Materials and methods: An electronic survey evaluating the management of stage I seminoma patients was sent to Canadian radiation oncologists to determine their treatment recommendations and preferences.

Results: The survey completion rate was 74% among eligible respondents (78/105). Most (56%) felt that surveillance was the preferred treatment for patients, whereas 31% thought that adjuvant radiotherapy was best, 1% chose adjuvant chemotherapy as being the preferred option and 12% were unsure. Most would choose the same treatment for themselves if they were diagnosed with stage I seminoma. A previously published survey found that most respondents considered radiotherapy as the best option.

Conclusions: Most Canadian radiation oncologists now favour surveillance for most stage I seminoma patients.

MeSH terms

  • Canada
  • Chemotherapy, Adjuvant / statistics & numerical data
  • Health Care Surveys*
  • Humans
  • Male
  • Neoplasm Staging
  • Orchiectomy / statistics & numerical data
  • Radiation Oncology / statistics & numerical data*
  • Radiotherapy, Adjuvant / statistics & numerical data
  • Seminoma / pathology
  • Seminoma / therapy*
  • Surveys and Questionnaires
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / therapy*